Company Filing History:
Years Active: 1999
Title: Franklin Porter Bymaster: Innovator in Alzheimer's Treatment
Introduction
Franklin Porter Bymaster is a notable inventor based in Brownburg, IN (US). He has made significant contributions to the field of medicine, particularly in the treatment of Alzheimer's Disease. His innovative approach has led to the development of a unique transdermal formulation that aims to improve patient outcomes.
Latest Patents
Bymaster holds 1 patent for his invention titled "Transdermal formulation of xanomeline." This patent provides a method for treating Alzheimer's Disease using a xanomeline transdermal formulation. The invention focuses on creating effective transdermal xanomeline patch formulations that can enhance the delivery of the medication.
Career Highlights
Franklin Porter Bymaster is associated with Eli Lilly and Company, a leading pharmaceutical firm known for its commitment to innovation in healthcare. His work at Eli Lilly has allowed him to contribute to groundbreaking research and development in the field of neurology.
Collaborations
Bymaster has collaborated with esteemed colleagues such as Michael Horstmann and Harlan E Shannon. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in medical research.
Conclusion
Franklin Porter Bymaster's contributions to the treatment of Alzheimer's Disease through his innovative transdermal formulation exemplify the impact of dedicated inventors in the medical field. His work continues to inspire advancements in healthcare and improve the lives of patients.